Genome Medicine | Authorisation | The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy

Van Roy N, De Preter K, Hoebeeck J, Van Maerken T, Pattyn F, Mestdagh P, Vermeulen J, Vandesompele J et al.

Genome Medicine 2009, 1:74 (27 July 2009)

Access to the PDF and full text of this article requires a subscription (the abstract is freely accessible)

If you have trouble accessing your subscription, email us: info@genomemedicine.com